Literature DB >> 1730481

Characterization of a cellular protease that cleaves Pseudomonas exotoxin.

C Fryling1, M Ogata, D FitzGerald.   

Abstract

Pseudomonas exotoxin (PE) is a 66-kDa bacterial toxin that is proteolytically cleaved by cells to produce an N-terminal fragment of 28 kDa and a C-terminal 37-kDa fragment which translocates to the cytosol and inhibits protein synthesis (M. Ogata, V.K. Chaudhary, I. Pastan, and D.J. FitzGerald, J. Biol. Chem. 265:20678-20685, 1990). When cells were broken by homogenization, the appropriate proteolytic activity was found associated with cellular membranes and not in a soluble fraction. Proteolysis of PE by crude membranes was stimulated by divalent cations, was ATP independent, and had a pH optimum of 5.5. When cells were disrupted by nitrogen cavitation and fractionated on Percoll gradients, proteolytic activity was present in fractions corresponding to the density of plasma membranes or endosomes but not in fractions containing lysosomes. Proteolytic activity was recovered in detergent extracts after crude membranes were treated with Nonidet P-40 or octylglucoside. Proteolysis of PE by either crude membranes or detergent extracts generated fragments of 28 and 37 kDa. The sizes of these fragments resembled those produced by intact cells. However, when the nontoxic mutant, PEgly276, which cannot be cleaved appropriately by intact cells, was incubated with membranes or extracts there was no production of the 28- and 37-kDa fragments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730481      PMCID: PMC257655          DOI: 10.1128/iai.60.2.497-502.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  22 in total

1.  Expression of enzymic activity by exotoxin A from Pseudomonas aeruginosa.

Authors:  S Lory; R J Collier
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

2.  Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.

Authors:  V K Chaudhary; Y Jinno; D FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 12.779

3.  Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation.

Authors:  R E Morris; A S Gerstein; P F Bonventre; C B Saelinger
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Proteolytic cleavage of epidermal growth factor receptor. A Ca2+-dependent, sulfhydryl-sensitive proteolytic system in A431 cells.

Authors:  D Cassel; L Glaser
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

5.  A dipeptide insertion in domain I of exotoxin A that impairs receptor binding.

Authors:  G J Chaudry; R B Wilson; R K Draper; R C Clowes
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.486

6.  Involvement of denaturation-like changes in Pseudomonas exotoxin a hydrophobicity and membrane penetration determined by characterization of pH and thermal transitions. Roles of two distinct conformationally altered states.

Authors:  J X Jiang; E London
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.486

7.  Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.

Authors:  M Ogata; V K Chaudhary; I Pastan; D J FitzGerald
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.486

Review 8.  Pseudomonas exotoxin: chimeric toxins.

Authors:  I Pastan; D FitzGerald
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.486

9.  Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.

Authors:  Y Sanai; K Morihara; H Tsuzuki; J Y Homma; I Kato
Journal:  FEBS Lett       Date:  1980-10-20       Impact factor: 3.864

10.  Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step.

Authors:  R E Morris; M D Manhart; C B Saelinger
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.609

View more
  15 in total

Review 1.  Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

2.  A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen.

Authors:  V M Gordon; A Rehemtulla; S H Leppla
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

Authors:  John F Langenheim; Wen Y Chen
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

Review 4.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 5.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

Review 6.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

Review 7.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 8.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

9.  Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.

Authors:  C C Grant; R J Messer; W Cieplak
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.

Authors:  V M Gordon; K R Klimpel; N Arora; M A Henderson; S H Leppla
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.